AKT1 and autoimmune thrombocytopenic purpura: Yuan Kong et al. showed that the p38 MAPK pathway downregulation and the Akt pathway upregulation induced by atorvastatin could improve the quantity and function of EPCs from bone marrow in corticosteroid-resistant ITP patients [30].